SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study. (June 2022)
- Record Type:
- Journal Article
- Title:
- SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study. (June 2022)
- Main Title:
- SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study
- Authors:
- Backhaus, I.
Hermsen, D.
Timm, J.
Boege, F.
Lübke, N.
Degode, T.
Göbels, K.
Dragano, N. - Abstract:
- Abstract: Objectives: Most SARS-CoV-2 seroprevalence studies have focussed on adults and high-risk populations, and little is known about young adults. The objective of the present study was to provide evidence on the SARS-CoV-2 seroprevalence among young adults in Germany and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections. Study design: This was a population-based SARS-CoV-2 seroprevalence study. Methods: In November 2020, a population-based study on SARS-CoV-2 seroprevalence in young adults (aged 18–30 years) was conducted in a large German city. Serum samples were obtained to analyse the SARS-CoV-2 antibody status using the Elecsys Anti-SARS-CoV-2 immunoassay. Descriptive statistics and odds ratios (ORs) of seropositivity and of previously undetected infections in relation to different determinants were calculated. Results: Among 2186 participants, SARS-CoV-2 antibodies were detected in 72 individuals, equalling a test performance-adjusted seroprevalence of 3.1% (95% confidence interval [CI]: 2.4–4.0). Based on reported COVID-19 cases to the public health authority, a moderate underascertainment rate of 1.7 was calculated. Seropositivity was higher among individuals who sought COVID-19-related information from social media (OR: 1.83, 95% CI: 1.2–3.1), and undetected COVID-19 infections were more prevalent among men and those not adhering to social distancing. Conclusions: The results show aAbstract: Objectives: Most SARS-CoV-2 seroprevalence studies have focussed on adults and high-risk populations, and little is known about young adults. The objective of the present study was to provide evidence on the SARS-CoV-2 seroprevalence among young adults in Germany and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections. Study design: This was a population-based SARS-CoV-2 seroprevalence study. Methods: In November 2020, a population-based study on SARS-CoV-2 seroprevalence in young adults (aged 18–30 years) was conducted in a large German city. Serum samples were obtained to analyse the SARS-CoV-2 antibody status using the Elecsys Anti-SARS-CoV-2 immunoassay. Descriptive statistics and odds ratios (ORs) of seropositivity and of previously undetected infections in relation to different determinants were calculated. Results: Among 2186 participants, SARS-CoV-2 antibodies were detected in 72 individuals, equalling a test performance-adjusted seroprevalence of 3.1% (95% confidence interval [CI]: 2.4–4.0). Based on reported COVID-19 cases to the public health authority, a moderate underascertainment rate of 1.7 was calculated. Seropositivity was higher among individuals who sought COVID-19-related information from social media (OR: 1.83, 95% CI: 1.2–3.1), and undetected COVID-19 infections were more prevalent among men and those not adhering to social distancing. Conclusions: The results show a substantial underascertainment of SARS-CoV-2 infections among young adults and indicate that seroprevalence is likely to be much higher than the reported COVID-19 prevalence based on confirmed COVID-19 cases in Germany. Preventive efforts should consider the heterogeneity of risk profiles among the young adult population. … (more)
- Is Part Of:
- Public health. Volume 207(2022)
- Journal:
- Public health
- Issue:
- Volume 207(2022)
- Issue Display:
- Volume 207, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 207
- Issue:
- 2022
- Issue Sort Value:
- 2022-0207-2022-0000
- Page Start:
- 54
- Page End:
- 61
- Publication Date:
- 2022-06
- Subjects:
- Seroprevalence -- SARS-CoV-2 antibodies -- COVID-19 -- Young adults
Public health -- Periodicals
Public health -- Periodicals
Electronic journals
362.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00333506 ↗
http://intl.elsevierhealth.com/journals/pubh/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00333506 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00333506 ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/public-health ↗ - DOI:
- 10.1016/j.puhe.2022.03.009 ↗
- Languages:
- English
- ISSNs:
- 0033-3506
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6963.850000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22338.xml